OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 16 citing articles:

Repurposing drugs targeting metabolic diseases for cancer therapeutics
Jisha Pillai U, Anindita Ray, Meenu Maan, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103684-103684
Closed Access | Times Cited: 16

Repurposing of Metformin to Improve Survival Outcomes in Patients With Upper Tract Urothelial Carcinoma
Hsiang‐Ying Lee, Po‐Hung Lin, See‐Tong Pang, et al.
Cancer Medicine (2025) Vol. 14, Iss. 1
Open Access

Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma
Edgar Xchel Franco-Juárez, Vianey González-Villasana, María Elena Camacho-Moll, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1760-1760
Open Access | Times Cited: 4

A triple-drug combination induces apoptosis in cervical cancer-derived cell lines
Izamary Delgado-Waldo, Carlos Contreras-Romero, Sandra Salazar-Aguilar, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6

PI3K/Akt signaling in urological cancers: Tumorigenesis function, therapeutic potential, and therapy response regulation
Sahar Rezaei, Negin Nikpanjeh, Aryan Rezaee, et al.
European Journal of Pharmacology (2023) Vol. 955, pp. 175909-175909
Closed Access | Times Cited: 5

Ianus Bifrons: The Two Faces of Metformin
Umberto Goglia, Iderina Hasballa, Claudia Teti, et al.
Cancers (2024) Vol. 16, Iss. 7, pp. 1287-1287
Open Access | Times Cited: 1

mTOR Dysregulation, Insulin Resistance, and Hypertension
Silviu Stanciu, Mariana Jinga, Daniela Miricescu, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1802-1802
Open Access | Times Cited: 1

Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases
Hemin Ashayeri Ahmadabad, Somayeh Mohammadi Panah, Hojat Ghasemnejad‐Berenji, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 1

Evaluation of metformin’s effect on the adult and juvenile stages of Schistosoma mansoni: an in-vitro study
Heba Nasser Abdel Menaem, Marmar Ahmed Hanafy, Marwa Abou El Dahab, et al.
Journal of Parasitic Diseases (2024) Vol. 49, Iss. 1, pp. 69-83
Closed Access

Metformin: Beyond Type 2 Diabetes Mellitus
Rahnuma Ahmad, Mainul Haque
Cureus (2024)
Open Access

Anti-Diabetic Therapies and Cancer: From Bench to Bedside
Dimitris Kounatidis, Natalia G. Vallianou, Ιrene Karampela, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1479-1479
Open Access

Network Pharmacology-Integrated Molecular Docking Reveals the Expected Anticancer Mechanism of Picrorhizae Rhizoma Extract
Xiaomeng Hu, Shengchao Zhao, Yi Cai, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 1

The Role of Specificity Protein 1 (SP1) in Bladder Cancer Progression through PTEN-Mediated AKT/mTOR Pathway
Zhiqiang Chen
Urologia Internationalis (2023) Vol. 107, Iss. 9, pp. 848-856
Closed Access

Anti-cancer Efficacy of Metformin: Recent Updates on Breast and Other Cancers
Md. Imtiazul Kabir, Robin Kumar, Lakshmi Sai Pratyusha Bugata, et al.
Current Pharmacology Reports (2023) Vol. 9, Iss. 5, pp. 284-328
Closed Access

The endocrinology of the urinary bladder
Saptarshi Bhattacharya, Arbinder Singal, Sanjay Kalra
Journal of the Pakistan Medical Association (2023) Vol. 73, Iss. 12, pp. 2488-2490
Open Access

Page 1

Scroll to top